Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 80.05
+0.35 (0.44%)
Feb 27, 2026, 2:52 PM CET
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 21.13 billion as of February 27, 2026. Its market cap has decreased by -40.63% in one year.
Market Cap
21.13B
Enterprise Value
20.95B
Revenue
6.09B
Ranking
n/a
PE Ratio
39.10
Stock Price
80.05
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 21.13B, an increase of 7,184.69%. That is a compound annual growth rate of 14.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 20.77B | -11.30% |
| Dec 30, 2025 | 23.42B | -15.47% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 112.95B |
| Coloplast | 108.53B |
| ALK-Abelló | 46.53B |
| Demant | 39.48B |
| H. Lundbeck | 37.97B |
| Zealand Pharma | 25.42B |
| Bavarian Nordic | 15.26B |